Start-Up Previews, July-August 2013
This Month's Profile Groups: Ocular Gene Therapy Sees The Light, features profiles of Avalanche Biotechnologies, Eyevensys, GenSight Biologics, and Hemera Biosciences; Smart Orthopedic Implants, feature profiles of OrthoData and Ortho-tag. Plus these Start-Ups Across Health Care: Colibri Heart Valve, Complix, Helmedix, Mapi Pharma, Mendor, Oligomerix, QuantuMDx, Silicon BioDevices, and Vigilant Biosciences.
You may also be interested in...
Silicon BioDevices Inc. is looking to save critical time in heart attack diagnosis as well as billions of dollars in health care costs with the first lab-quality, reader-free, POC device for high-sensitivity measurement of cardiac troponin, a key marker of cardiac damage. Using one drop of whole blood, the company's self-contained blood test provides results within 15 minutes to determine whether or not a patient has experienced a heart attack.
Vigilant Biosciences Inc.’s screening kit for diagnosing early-stage oral cancer comprises a test strip to detect oral cancer biomarkers, and an oral gargle-and-spit rinse. The screening is designed to occur annually at dental check-ups and it can be administered by a hygienist.
Mendor Ltd. says it’s unique in the diabetes space because it has integrated its diagnostic blood glucose meter Discreet with a software application for tailoring patient pharmaceutical treatment. Using the device, which contains a built-in lancing pen and cartridge within a cell-phone-sized plastic cover, diabetics can take their glucose readings in less than 20 seconds, even on the run.